Report Company Directory
- UCB Kygevvi receives EC approval in ultra-rare disease TK2d by KBC Securities
- Morning Notes : AGFB BB, GLPG NA, IVA FP, UCB BB, WDP BB, MAAT FP, ONWD BB by KBC Securities
- Morning Notes : HAL NA, UCB BB, DEME BB, AUTL US, JDEP NA by KBC Securities
- UCB New Bimzelx data in HS and PsO at AAD 2026 by KBC Securities
- Morning Notes : COMB BB, HYL BB, TESB BB, UCB BB by KBC Securities
- UCB/EmBOLDened by Bimzelx/BUY by ING Financial Markets
- Morning Notes : TINC BB, UCB BB, VPK NA, ZEAL DC by KBC Securities
- UCB Picks Georgia site for planned US manufacturing facility by KBC Securities
- Healthcare Conference - Key Takeaways by BNP Paribas
- Keeping up with the Catalyst-ians: 2Q26 Edition by BNP Paribas